Home » Stocks » GBLX

GB Sciences, Inc. (GBLX)

Stock Price: $0.0291 USD 0.0010 (3.56%)
Updated November 27, 12:48 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 7.78M
Revenue (ttm) 1.59M
Net Income (ttm) -9.94M
Shares Out 267.43M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $0.0291
Previous Close $0.0281
Change ($) 0.0010
Change (%) 3.56%
Day's Open 0.0286
Day's Range 0.0278 - 0.0295
Day's Volume 118,458
52-Week Range 0.02 - 0.065

More Stats

Market Cap 7.78M
Enterprise Value 10.03M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 267.43M
Float n/a
EPS (basic) -0.04
EPS (diluted) -0.04
FCF / Share 0.00
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.18
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.90
PB Ratio 1.08
Revenue 1.59M
Operating Income -9.38M
Net Income -9.94M
Free Cash Flow -1.13M
Net Cash -2.24M
Net Cash / Share -0.01
Gross Margin -28.25%
Operating Margin -590.09%
Profit Margin -625.10%
FCF Margin -71.10%
ROA -14.99%
ROE -173.62%
ROIC -71.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue3.123.452.51-----
Revenue Growth-9.67%37.61%------
Gross Profit-0.880.211.73-----
Operating Income-12.01-13.19-17.82-8.93-6.96-7.97-0.19-0.11
Net Income-12.37-23.65-22.97-9.91-6.77-7.72-0.660.04
Shares Outstanding25821013379.0044.9129.520.940.97
Earnings Per Share-0.05-0.11-0.17-0.13-0.15-0.26-0.700.04
Operating Cash Flow-4.48-9.86-12.25-4.47-3.56-3.50-0.36-0.04
Capital Expenditures-0.19-1.51-3.43-3.05-0.88-0.94-0.02-
Free Cash Flow-4.67-11.37-15.68-7.52-4.45-4.44-0.38-0.04
Cash & Equivalents5.380.183.582.690.03-0.340.34
Total Debt10.006.127.553.932.610.181.271.27
Net Cash / Debt-4.63-5.94-3.97-1.24-2.58-0.18-0.93-0.93
Assets14.3530.0224.0513.012.441.450.540.54
Liabilities14.4412.878.424.604.413.381.551.55
Book Value-0.098.3012.758.33-1.90-1.68-1.01-1.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name GB Sciences, Inc.
Country United States
Employees 23
CEO John Claybron Poss

Stock Information

Ticker Symbol GBLX
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: GBLX

Description

GB Sciences engages in the research and development of cannabinoid medicines in North America and Europe. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.